Published in Acta Paediatr Scand Suppl on January 01, 1989
Enzyme replacement therapy for mucopolysaccharidosis VI: Growth and pubertal development in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase. J Pediatr Rehabil Med (2010) 1.11
Different features of coeliac disease in two neighbouring countries. Arch Dis Child (1993) 0.96
Principles of growth standards. Acta Paediatr Scand (1990) 0.88
Proteins related to lipoprotein profile were identified using a pharmaco-proteomic approach as markers for growth response to growth hormone (GH) treatment in short prepubertal children. Proteome Sci (2009) 0.85
Age-specific carcinogenesis: environmental exposure and susceptibility. Environ Health Perspect (1995) 0.81
National growth charts for the United Arab Emirates. J Epidemiol (2008) 0.77
Different thresholds of tissue-specific dose-responses to growth hormone in short prepubertal children. BMC Endocr Disord (2012) 0.76
Growth failure starts from early infancy in children with short stature at age 6. Clin Pediatr Endocrinol (2015) 0.75
Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain. BMC Endocr Disord (2015) 0.75
Analysis of linear growth using a mathematical model. II. From 3 to 21 years of age. Acta Paediatr Scand Suppl (1987) 1.05
The infancy-childhood growth spurt. Acta Paediatr Scand Suppl (1990) 0.75
Weight-for-height standards in adulthood. J Intern Med (1991) 0.75